Urinary peptides enable assessment of disease severity in COVID-19

ABSTRACT: In this article, we report first data on the urinary test COVID31 that enables prediction of critical progression and death outcomes in COVID-19 patients. COVID31 is composed of 31 endogenous peptides mainly derived from various collagen chains that enable differentiation of moderate and severe disease courses from those that progress to a critical state or death. The test is based on non-invasive urine analysis and expected to have a major impact on the management of COVID-19 outpatients by guiding patient’s stratification towards timely and targeted intervention to improve disease outcome.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Urine

DISEASE(S): Covid-19

SUBMITTER: Martin Pejchinovski  

LAB HEAD: Martin Pejchinovski

PROVIDER: PXD020444 | Pride | 2020-09-28

REPOSITORIES: Pride